Vaginal Creams, Foams, and Jellies
"Vaginal Creams, Foams, and Jellies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.
| Descriptor ID |
D014622
|
| MeSH Number(s) |
D26.255.955 E07.357.750
|
| Concept/Terms |
Vaginal Tablet- Vaginal Tablet
- Tablet, Vaginal
- Tablets, Vaginal
- Vaginal Tablets
Vaginal Jelly- Vaginal Jelly
- Jellies, Vaginal
- Jelly, Vaginal
- Vaginal Jellies
- Vaginal Gel
- Gel, Vaginal
- Gels, Vaginal
- Vaginal Gels
Vaginal Creams- Vaginal Creams
- Cream, Vaginal
- Creams, Vaginal
- Vaginal Cream
Vaginal Foams- Vaginal Foams
- Foam, Vaginal
- Foams, Vaginal
- Vaginal Foam
|
Below are MeSH descriptors whose meaning is more general than "Vaginal Creams, Foams, and Jellies".
Below are MeSH descriptors whose meaning is more specific than "Vaginal Creams, Foams, and Jellies".
This graph shows the total number of publications written about "Vaginal Creams, Foams, and Jellies" by people in this website by year, and whether "Vaginal Creams, Foams, and Jellies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaginal Creams, Foams, and Jellies" by people in Profiles.
-
Hoang T, Zierden H, Date A, Ortiz J, Gumber S, Anders N, He P, Segars J, Hanes J, Mahendroo M, Ensign LM. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth. J Control Release. 2019 02 10; 295:74-86.
-
Makarova N, Henning T, Taylor A, Dinh C, Lipscomb J, Aubert R, Hanson D, Phillips C, Papp J, Mitchell J, McNicholl J, Garcia-Lerma GJ, Heneine W, Kersh E, Dobard C. Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. AIDS. 2017 03 27; 31(6):745-752.
-
Destache CJ, Mandal S, Yuan Z, Kang G, Date AA, Lu W, Shibata A, Pham R, Bruck P, Rezich M, Zhou Y, Vivekanandan R, Fletcher CV, Li Q. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model. Antimicrob Agents Chemother. 2016 06; 60(6):3633-9.
-
Kovarova M, Council OD, Date AA, Long JM, Nochi T, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog. 2015 Aug; 11(8):e1005075.
-
McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 2011 May 15; 25(8):1057-64.
-
MacLennan AH, Kerin JF, Kirby C, Grant P, Warnes GM, Cox LW, Bryant-Greenwood G, Greenwood F. The effect of porcine relaxin vaginally applied at human embryo transfer in an in vitro fertilization programme. Aust N Z J Obstet Gynaecol. 1985 Feb; 25(1):68-71.